Bronchopulmonary Dysplasia (BPD) Clinical Trial
Official title:
Efficacy and Safety of No Treatment Compared With Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants: a Randomized, Double-blind, Placebo-controlled, Non-inferiority Clinical Trial
The purpose of this study is to evaluate the efficacy and safety of no treatment compared with ibuprofen treatment for patent ductus arteriosus in preterm infants. The study hypothesis is that no treatment is not inferior to oral ibuprofen treatment in preterm infants. (non-inferiority study)
This study is a randomized, double-blind, placebo-controlled, non-inferiority clinical trial. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02907593 -
Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06409299 -
Enhancing Lung Health in Kids With Structural Lung Damage and Malformations: Azithromycin (AZI) for Airway Infection Prevention
|
Phase 3 | |
| Completed |
NCT01223287 -
Physiologic Definition of Bronchopulmonary Dysplasia
|
N/A | |
| Completed |
NCT00067613 -
Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
|
N/A | |
| Completed |
NCT00349726 -
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
|
Phase 2 | |
| Completed |
NCT01516398 -
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
|
||
| Completed |
NCT04756297 -
Lung Ultrasound for Prediction of Bronchopulmonary Dysplasia
|
||
| Completed |
NCT01030575 -
Multi-dose Pharmacokinetics and Dose Ranging of Inositol in Premature Infants (INS-2)
|
Phase 2 | |
| Completed |
NCT02163681 -
MRI for Non-Invasive Imaging in Neonates and Children
|
N/A | |
| Active, not recruiting |
NCT01702805 -
Transfusion of Prematures Trial
|
Phase 3 | |
| Active, not recruiting |
NCT04545866 -
The Budesonide in Babies (BiB) Trial
|
Phase 3 |